Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Halo Oral Spray for Prevention of Acute Upper Respiratory Disease
NCT02644135Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Jan 2013
- Primary completion
- Jun 2013
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in acute upper respiratory infection (URI) and respiratory virus infection (RTI) comparing Halo Oral Spray with Halo Placebo (2 arms). Primary endpoint: Number of Participants That Develop Acute Respiratory Illnesses When Using Halo vs Placebo at 3 months. Started Jan 2013; status: completed.
02
Drugs
cetylpyridinium chloride
03
Conditions
acute upper respiratory infection (URI)respiratory virus infection (RTI)
Beyond the preview
Go deeper on NCT02644135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02644135.